In this podcast, Cleaven Pagani, Rick Waines, Paul Wilton and Emil Wijnker, all with severe hemophilia A and also members of the Canadian Hemophilia Society Blood Safety and Supply Committee, are asked to debate the question: “If gene therapy f

What Other Approaches To Hemophilia Gene Therapies Are Down The Road?

Dec 18th, 2023 20m 57s

The first generation of gene therapy for hemophilia, called gene insertion or gene addition, is now a reality, but it is not for everyone. Dr. Glenn Pierce explores other approaches to gene therapy in the research pipeline that in the future ma

How Might Gene Therapy Be Delivered In Canada?

Dec 14th, 2023 12m 14s

In this podcast, Dr. Jerry Teitel explores how gene therapy for hemophilia A and hemophilia B might be delivered to patients across Canada in an equitable way, even though the administration will occur in only some sites. He describes the follo

How Might Gene Therapy Be Funded In Canada?

Dec 12th, 2023 20m 5s

Gene therapy—a high-cost, one-time, potentially life-changing treatment—presents unique challenges for governments that make decisions on funding innovative treatments. Dr. Durhane Wong-Rieger presents creative ideas on new ways to think about

What Is The Shared Decision-Making Process In Hemophilia Gene Therapy?

Dec 7th, 2023 14m 40s

In this podcast, Dr. Jerry Teitel describes the process of shared decision-making prior to gene therapy in hemophilia A and hemophilia B, and how the nature of gene therapy itself makes shared decision-making so important. Dr. Teitel is a Profe

What Don’t We Know About Gene Therapy For Hemophilia?

Dec 5th, 2023 23m 28s

In this podcast, Dr. Glenn Pierce explores what we know we don’t know and what we don’t even know we don’t know about the brand-new treatment which is gene therapy for hemophilia A and B. Glenn is a long-time researcher in coagulation products

What Is It Like To Receive Gene Therapy?

Dec 1st, 2023 12m 37s

In this podcast, Brian O’Mahony explores the patient experience of gene therapy for hemophilia, from the shared decision-making process prior to gene therapy, to the administration itself, to the intense follow-up in the first months and finall

What Are The Clinical Trial Results In Hemophilia Gene Therapy?

Nov 30th, 2023 13m 53s

In this podcast, Dr. David Lillicrap presents the results of clinical trials in hemophilia A and hemophilia B gene therapy. He describes how high factor VIII and IX levels can rise, how predictable this response is from person to person, and ho

Who Is Eligible For Hemophilia Gene Therapy?

Nov 17th, 2023 18m 14s

In this podcast, Brian O’Mahony explores why gene therapy for hemophilia A and Hemophilia B is not for all patients. He describes what makes a person eligible, and in some cases ineligible, to receive the treatment. Brian is Chief Executive Off

What Is Gene Therapy For Hemophilia?

Nov 16th, 2023 15m 9s

In this podcast, Dr. David Lillicrap describes in easy-to-understand language what gene therapy for hemophilia A and hemophilia B is, how it is administered and how it works. Dr. Lillicrap is a Professor in the Department of Pathology and Molec

Trailer

Introducing: Gene Therapy for Hemophilia: Dream or Reality?

Nov 15th, 2023 1m 17s

This is a series of podcasts featuring well-known patient and physician experts will provide important answers, for example: What are the clinical trial results in hemophilia GT? What is the shared decision-making process in hemophilia GT? What

Rate